Back to Journals » Clinical Interventions in Aging » Volume 4

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients

Authors Karagiannis D, Soublis V, Kandarakis A

Published 26 June 2009 Volume 2009:4 Pages 315—317

DOI https://doi.org/10.2147/CIA.S6193

Review by Single-blind

Peer reviewer comments 2

Dimitrios A Karagiannis, Vasilios Soublis, Artemios Kandarakis

1st Ophthalmology Department of Ophthalmiatrio Eye Hospital of Athens, Athens, Greece

Background: To report a case of peripheral polypoidal choroidal vasculopathy (PCV) which was treated successfully.

Methods: Interventional case report. Best-corrected visual acuity measurements (BCVA), slit-lamp examination, fundus biomicroscopy, fluorescein angiography (FFA), and indocyanine green angiography (ICGA) were performed at baseline examination and during the follow-up period. The patient underwent ICGA-guided argon laser to treat the active polyps.

Results: An 82-year-old Caucasian man presented complaining of sudden deterioration of peripheral vision in his left eye (LE). His previous ocular history was associated with advanced age-related macular degeneration (AMD) involving both eyes (BE). Fundus examination revealed macular scars in BE and a large hemorrhagic pigment epithelial detachment (PED) temporal to the macula in the LE. ICGA revealed active polyps at the margins of the PED. The patient underwent ICGA-guided argon laser to treat the active polyps. Six months post-laser, the patient regained his peripheral vision with resolution of the hemorrhagic PED and remains stable until now, one year after treatment.

Conclusions: Appropriate treatment and regular follow-up is important in patients with PCV and peripheral lesions even if central vision is lost.

Keywords: argon laser, peripheral vision, polypoidal choroidal vasculopathy

General overview

Idiopathic polypoidal choroidal vasculopthy (PCV) represents about 8%–10% of cases of exudative maculopathy and is an exudative disorder of the macula. Although its pathogenesis remains unclear, it is generally thought to be an inner choroidal vascular abnormality. Choroidal vascular lesions of PCV are more preferable found in the posterior pole of the retina, although further evidence suggests that the lesion could also be found in the peripheral retina up to 63%. We report a case of peripheral PCV, treated successfully, in a male patient with advanced bilateral age-related macular degeneration affecting severely both foveal areas. The initial complain of the patient was deterioration of peripheral vision in addition to the already affected central vision. Such a clinical situation may impair significantly the quality of life of the patient and needs to be promptly identified, diagnosed, and treated in order to preserve, in the best possible way, the peripheral vision of the patient.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration

Karagiannis D, Chatziralli I, Kaprinis K, Georgalas I, Parikakis E, Mitropoulos P

Clinical Interventions in Aging 2017, 12:1829-1833

Published Date: 3 November 2017

Spontaneous development of macular ischemia in a case of racemose hemangioma

Panagiotidis DDP, Karagiannis DA, Tsoumpris IIT

Clinical Ophthalmology 2011, 5:931-932

Published Date: 8 July 2011

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Dimitrios A Karagiannis, Ioannis D Ladas, Efstratios Parikakis, et al.

Clinical Interventions in Aging 2009, 4:457-461

Published Date: 26 November 2009

Readers of this article also read:

Hematuria following Botox treatment for upper limb spasticity: a case report

Lo TC, Yeung ST, Lee S, Chang EY

Journal of Pain Research 2015, 8:619-622

Published Date: 14 September 2015

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010